Evidence map›Paper›PMID 23665202›Full record

ArticleThe American journal of pathology2013

Spdef null mice lack conjunctival goblet cells and provide a model of dry eye.

Christina K Marko, Balaraj B Menon, Gang Chen, Jeffrey A Whitsett, Hans Clevers, Ilene K Gipson

3 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04980144 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Four-week Randomized Control, Single Masked Pilot Study.

TypeinterventionalSponsorHe Eye HospitalRan2023 to 2023Enrolled101ConditionsDiabetic Eye ProblemsArms3% Diquafosol tetrasodium, 0.1% hyaluronate
NCT05193331 naunknown statusnot on this mapstarted 2023, after this paper: background citation

3% Diquafosol Topical Ophthalmic Solution in Diabetic Patients With Dry Eye

TypeinterventionalSponsorHe Eye HospitalRan2023 to 2023Enrolled70ConditionsDiabetic Eye ProblemsArms3% Diquafosol tetrasodium
NCT05682547 nacompletednot on this mapstarted 2022, after this paper: background citation

A Single Center, Randomized, Controlled Trial Comparing the Clinical Efficacy of 3% Diquafosol Tetrasodium and 0.1 % Hyaluronic Acid 0.1% in Diabetic Patients With Dry Eye Disease

TypeinterventionalSponsorHe Eye HospitalRan2022 to 2023Enrolled99ConditionsDiabetic Eye ProblemsArms3% Diquafosol tetrasodium, 0.1% hyaluronate
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 100 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ectopic lymphoid structures in the aged lacrimal glands.Clinical immunology (Orlando, Fla.) · 2023
    Article
  7. Review
  8. Review
  9. Anti-Oxidative and Anti-Inflammatory Micelles: Break the Dry Eye Vicious Cycle.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Dupilumab-Associated Mucin Deficiency (DAMD).Translational vision science & technology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Christina K MarkoDepartment of Ophthalmology, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts 02114, USA.
Balaraj B Menon
Gang Chen
Jeffrey A Whitsett
Hans Clevers
Ilene K Gipson
Harvard University · USUniversity of Cincinnati · USHubrecht Institute for Developmental Biology and Stem Cell Research · NLMassachusetts Eye and Ear Infirmary · US

Funding

MUCINS OF THE OCULAR SURFACER01EY003306 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI GIPSON, ILENE K. · 1985 to 2015
$8.9M
Transcriptional Programming of Asthma Related Pathology in Respiratory EpitheliaR01HL095580 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WHITSETT, JEFFREY A · 2009 to 2017
$4.7M
NEI NIH HHS R01 EY003306NEI NIH HHS R01 EY03306NEI NIH HHS R01 EY03306-S1NHLBI NIH HHS R01 HL095580
6 · The paper itself

Abstract

Goblet cell numbers decrease within the conjunctival epithelium in drying and cicatrizing ocular surface diseases. Factors regulating goblet cell differentiation in conjunctival epithelium are unknown. Recent data indicate that the transcription factor SAM-pointed domain epithelial-specific transcription factor (Spdef) is essential for goblet cell differentiation in tracheobronchial and gastrointestinal epithelium of mice. Using Spdef(-/-) mice, we determined that Spdef is required for conjunctival goblet cell differentiation and that Spdef(-/-) mice, which lack conjunctival goblet cells, have significantly increased corneal surface fluorescein staining and tear volume, a phenotype consistent with dry eye. Microarray analysis of conjunctival epithelium in Spdef(-/-) mice revealed down-regulation of goblet cell-specific genes (Muc5ac, Tff1, Gcnt3). Up-regulated genes included epithelial cell differentiation/keratinization genes (Sprr2h, Tgm1) and proinflammatory genes (Il1-α, Il-1β, Tnf-α), all of which are up-regulated in dry eye. Interestingly, four Wnt pathway genes were down-regulated. SPDEF expression was significantly decreased in the conjunctival epithelium of Sjögren syndrome patients with dry eye and decreased goblet cell mucin expression. These data demonstrate that Spdef is required for conjunctival goblet cell differentiation and down-regulation of SPDEF may play a role in human dry eye with goblet cell loss. Spdef(-/-) mice have an ocular surface phenotype similar to that in moderate dry eye, providing a new, more convenient model for the disease.

Indexed as

Disease Models, AnimalAnimalsBiomarkersCell DifferentiationConjunctivaDown-RegulationDry Eye SyndromesFemaleGenetic MarkersGoblet CellsHumansImmunohistochemistryMaleMiceMice, 129 StrainMice, Inbred C57BLBiomarkersGenetic MarkersProto-Oncogene Proteins c-etsRNASpdef protein, mouse

Identifiers

PMID23665202
PMCPMC3702735
OpenAlexW2129476710

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.